Pharmaceuticals

From Frenzy Capital
Jump to navigation Jump to search

Symbol Name Rank Change Headline Date
HZNP Horizon Therapeutics Plc 5.81 30.8077 Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi - Reuters 11/29/2022, 18:12:00
HZNP Horizon Therapeutics Plc 5.81 30.8077 Other news to note for Nov. 29, 2022 - BioWorld Online 11/29/2022, 17:41:50
HZNP Horizon Therapeutics Plc 5.81 30.8077 UK to Relax Ring-Fencing of Banks as Part of Brexit ‘Big Bang’ - Yahoo Canada Finance 11/29/2022, 17:40:51
HZNP Horizon Therapeutics Plc 5.81 30.8077 Canadian Dollar Tumbles as Economic Data Show Signs of Slowdown - Yahoo Canada Finance 11/29/2022, 14:37:38
HZNP Horizon Therapeutics Plc 5.81 30.8077 AstraZeneca Takes Personalized Approach To Cell Therapy With Neogene Buy - Scrip 11/29/2022, 12:37:43
MRK Merck & Co Inc 3.38 0.332 Horizon Therapeutics in Separate Sale Talks With Amgen, Sanofi, J&J - Bloomberg 11/29/2022, 17:30:04
MRK Merck & Co Inc 3.38 0.332 Roche Withdraws Tecentriq's Frontline Bladder Cancer Indication, Ceding Market To Keytruda - Scrip 11/29/2022, 17:25:16
MRK Merck & Co Inc 3.38 0.332 Merck & Co. Inc. stock rises Tuesday, outperforms market - MarketWatch 11/29/2022, 17:20:00
MRK Merck & Co Inc 3.38 0.332 Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022 - Yahoo Finance 11/29/2022, 16:43:00
MRK Merck & Co Inc 3.38 0.332 Gilead And Arcus' Latest Update Keeps TIGIT Hopes Afloat - Scrip 11/29/2022, 12:50:33
CPHI China Pharma Holdings Inc. 3.17 32.2094 Deal Watch: BMS Backs Out Of UniQure Gene Therapy Collaboration - Scrip 11/29/2022, 18:32:45
CPHI China Pharma Holdings Inc. 3.17 32.2094 Other news to note for Nov. 29, 2022 - BioWorld Online 11/29/2022, 17:41:50
CPHI China Pharma Holdings Inc. 3.17 32.2094 ADVA Optical Networking SE: Amount of the Recurring Compensation Payment under Domination and Profit and Loss Transfer Agreement with ADTRAN Holdings, Inc. - Yahoo Finance UK 11/29/2022, 14:14:24
CPHI China Pharma Holdings Inc. 3.17 32.2094 AstraZeneca Takes Personalized Approach To Cell Therapy With Neogene Buy - Scrip 11/29/2022, 12:37:43
CPHI China Pharma Holdings Inc. 3.17 32.2094 Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday’s Mid-Day Sessio - Benzinga 11/29/2022, 11:47:48
CNSP Cns Pharmaceuticals Inc 3.16 -18.2126 Sector Update: Health Care Stocks Unable to Complete Tuesday Recovery MarketScreener - Marketscreener.com 11/29/2022, 16:02:04
CNSP Cns Pharmaceuticals Inc 3.16 -18.2126 Healthcare Stocks Moving Tuesday: APEN, ONCS, VAXX, PALI, CNSP, CINC, NUTX, BEAT - InvestorsObserver 11/29/2022, 14:20:03
CNSP Cns Pharmaceuticals Inc 3.16 -18.2126 Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday’s Mid-Day Sessio - Benzinga 11/29/2022, 11:47:48
CNSP Cns Pharmaceuticals Inc 3.16 -18.2126 Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday - InvestorPlace 11/29/2022, 07:54:05
CNSP Cns Pharmaceuticals Inc 3.16 -18.2126 KemPharm Announces Appointment of Christopher Posner as New Independent Director - Yahoo Finance 11/29/2022, 07:30:00
CTLT Catalent Inc. 2.48 0.5541 Asia-Pacific Nasal Spray Market 2022: Size, Share, Demand, Trends, Growth, Industry Analysis till 20 - PharmiWeb.com 11/29/2022, 09:20:27
CTLT Catalent Inc. 2.48 0.5541 Biopharmaceuticals Manufacturing Consumables Testing Market 2022 Report with an exclusive discount on purchase Focusing on Current Trends and Leading Fortune Companies with Forecast to 2029: Alcami Corporation, Merck KGaA - Digital Journal 11/29/2022, 02:02:13
CTLT Catalent Inc. 2.48 0.5541 Global Life Sciences BPO Market Size Is Expected To Reach Around Usd $ 3,13,453.6 Million By 2030 - EIN News 11/29/2022, 00:59:00
CTLT Catalent Inc. 2.48 0.5541 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.45% By Investing.com - Investing.com 11/28/2022, 16:25:00
CTLT Catalent Inc. 2.48 0.5541 CTLT stock spikes as Barclays says FDA cleared site violations (NYSE:CTLT) - Seeking Alpha 11/28/2022, 14:40:00
JNJ Johnson & Johnson 2.15 -0.6993 Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi - Reuters 11/29/2022, 18:12:00
JNJ Johnson & Johnson 2.15 -0.6993 Men’s Basketball to Host Johnson & Wales Wednesday Evening - Winston-Salem State 11/29/2022, 17:43:39
JNJ Johnson & Johnson 2.15 -0.6993 OWL, WIO co-host a networking reception during Hawaiian Eye - Ophthalmology Times 11/29/2022, 17:05:50
JNJ Johnson & Johnson 2.15 -0.6993 Eagles Release OT Roderick Johnson & RB Kennedy Brooks From PS - NFL Trade Rumors 11/29/2022, 16:33:03
JNJ Johnson & Johnson 2.15 -0.6993 Johnson & Johnson stock outperforms competitors despite losses on the day - MarketWatch 11/29/2022, 16:33:00
SCPH scPharmaceuticals Inc 1.73 4.4199 Insider Buying: scPharmaceuticals Inc. (NASDAQ:SCPH) Major Shareholder Purchases 762380 Shares of Stock - MarketBeat 11/29/2022, 18:21:17
SCPH scPharmaceuticals Inc 1.73 4.4199 Orin Hirschman Discloses Position in SCPH / scPharmaceuticals - Nasdaq 11/26/2022, 18:06:00
SCPH scPharmaceuticals Inc 1.73 4.4199 Does Scpharmaceuticals Inc (SCPH) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver 11/22/2022, 13:07:12
SCPH scPharmaceuticals Inc 1.73 4.4199 Financings for Nov. 22, 2022 BioWorld - BioWorld Online 11/22/2022, 11:00:00
SCPH scPharmaceuticals Inc 1.73 4.4199 Pre-Market Brief: Stocks Rebound As Bond Yields Fall, China's COVID Spike Remains In Focus - Barchart 11/22/2022, 05:20:00
SNY Sanofi - ADR 0.81 1.0101 How Will the Market React to BioNTech SE - ADR (BNTX) Stock Getting a Bullish Rating - InvestorsObserver 11/29/2022, 11:06:38
SNY Sanofi - ADR 0.81 1.0101 Global Hepatitis B Vaccines Market 2022 Size and Share that Value Expected to Reach USD 1205.36 Mn Growing at CAGR of 2.28% Forecast to 2027 - Digital Journal 11/29/2022, 05:25:06
SNY Sanofi - ADR 0.81 1.0101 European ADRs Move Slightly Lower in Friday Trading - InvestorsObserver 11/11/2022, 11:14:45
SNY Sanofi - ADR 0.81 1.0101 Pharma Stock Roundup: Q3 Earnings of BAYRY, AZN, EU Nod for AZN, SNY RSV Vaccine - Yahoo Finance 11/11/2022, 03:00:00
SNY Sanofi - ADR 0.81 1.0101 Biogen Announces New CEO - NBC10 Boston 11/10/2022, 14:20:54
JAGX Jaguar Health Inc 0.8 -3.295 Jaguar Health Inc (JAGX) Stock: What Does the Chart Say Tuesday? - InvestorsObserver 11/29/2022, 11:50:13
JAGX Jaguar Health Inc 0.8 -3.295 2nd Region lawmaker picked to lead Indiana Senate committee - The Times of Northwest Indiana 11/29/2022, 08:30:00
JAGX Jaguar Health Inc 0.8 -3.295 19 Beauty Brands Participating in Giving Tuesday 2022: Where to Shop for Beauty Products That Give Back - Allure 11/29/2022, 08:06:00
JAGX Jaguar Health Inc 0.8 -3.295 UK’s BooHoo Group Doubles Stake in Revolution Beauty - PYMNTS.com 11/28/2022, 17:07:30
JAGX Jaguar Health Inc 0.8 -3.295 Why Jaguar Land Rover has swapped reach for the right audience - PR Week 11/24/2022, 09:30:21
FREQ Frequency Therapeutics Inc 0.72 4.7619 Funding Roundup: Akeyless, Boost Security, CG Oncology, FogPharma, Kyte, Ordergroove, PayZen, Swell Energy, Vizit, WEKA, WorkJam, And Others - Pulse 2.0 11/29/2022, 12:57:00
FREQ Frequency Therapeutics Inc 0.72 4.7619 Nestlé reconsiders peanut allergy program two years after $2.6B buyout - Endpoints News 11/29/2022, 12:48:00
FREQ Frequency Therapeutics Inc 0.72 4.7619 SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Frequency Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors - Longview News-Journal 11/29/2022, 11:05:00
FREQ Frequency Therapeutics Inc 0.72 4.7619 Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Program at the American Epilepsy Society 2022 Annual Meeting - Yahoo Finance 11/29/2022, 07:30:00
FREQ Frequency Therapeutics Inc 0.72 4.7619 Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease - Yahoo Finance 11/29/2022, 07:00:00
KMPH KemPharm Inc 0.66 -2.1413 KemPharm Announces Appointment of Christopher Posner as New Independent Director - Yahoo Finance 11/29/2022, 07:30:00
KMPH KemPharm Inc 0.66 -2.1413 Imago stock soars on $1.35B Merck buyout - BioWorld Online 11/21/2022, 12:00:00
KMPH KemPharm Inc 0.66 -2.1413 KemPharm, Inc. Forecasted to Post FY2023 Earnings of ($0.37) Per Share (NASDAQ:KMPH) - MarketBeat 11/21/2022, 02:36:47
KMPH KemPharm Inc 0.66 -2.1413 Analysts Have Just Cut Their KemPharm, Inc. (NASDAQ:KMPH) Revenue Estimates By 11% - Yahoo Finance UK 11/20/2022, 07:33:47
KMPH KemPharm Inc 0.66 -2.1413 KemPharm (NASDAQ:KMPH) Upgraded by StockNews.com to "Hold" - MarketBeat 11/19/2022, 03:00:00
NVO Novo Nordisk - ADR 0.52 0.099 Novo Nordisk Earns 92 RS Rating, Showing Market Leadership - Investor's Business Daily 11/29/2022, 11:25:00
NVO Novo Nordisk - ADR 0.52 0.099 Stocks Showing Market Leadership: Novo Nordisk ADR Earns 92 RS Rating - Investor's Business Daily 11/29/2022, 03:00:00
NVO Novo Nordisk - ADR 0.52 0.099 PFE: 1 High-Dividend Stock to Add to Your Portfolio if You Haven't Already - StockNews.com 11/28/2022, 13:40:30
NVO Novo Nordisk - ADR 0.52 0.099 Eurozone PMI Data Supports European Equities - Marketscreener.com 11/23/2022, 11:20:02
NVO Novo Nordisk - ADR 0.52 0.099 European ADRs Continue to Trend Higher in Monday Trading - InvestorsObserver 11/14/2022, 11:08:41
PETQ PetIQ Inc 0.3 -1.7668 Simple Mills Appoints Sheryl O'Loughlin to Board of Directors - PetIQ (NASDAQ:PETQ) - Benzinga 11/29/2022, 08:03:00
PETQ PetIQ Inc 0.3 -1.7668 Pet Dental Care Market Study Providing Information on Top Key Players Mars, CVS Group, MedVet, Petco And More - Digital Journal 11/29/2022, 07:41:32
PETQ PetIQ Inc 0.3 -1.7668 Two dead, one wounded in shooting at Baxter Springs residence - Yahoo News 11/29/2022, 00:12:32
PETQ PetIQ Inc 0.3 -1.7668 Club Q shooting suspect's mom faces charges, documents show - Yahoo News 11/29/2022, 00:02:30
PETQ PetIQ Inc 0.3 -1.7668 Police complete scene investigation of Club Q shooting, update number of victims - Yahoo! Voices 11/29/2022, 00:01:56
SIGA SIGA Technologies Inc 0.27 0.1112 World Health Organization renames monkeypox as mpox (NASDAQ:SIGA) - Seeking Alpha 11/28/2022, 06:51:00
SIGA SIGA Technologies Inc 0.27 0.1112 So far only 2 cases of monkeypox detected Print Edition - The Sunday Times, Sri Lanka - The Sunday Times Sri Lanka 11/26/2022, 19:48:52
SIGA SIGA Technologies Inc 0.27 0.1112 Monkeypox Treatment Market Future Business Opportunities 2022-2028 SIGA Technologies Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA. - Digital Journal 11/21/2022, 08:00:33
SIGA SIGA Technologies Inc 0.27 0.1112 Global Biodefense Market Report to 2030 - Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others - ResearchAndMarkets.com - Business Wire 11/21/2022, 05:53:00
SIGA SIGA Technologies Inc 0.27 0.1112 SIGA Technologies is experiencing unusually high option volume. - Best Stocks 11/17/2022, 19:32:52
AZN Astrazeneca plc - ADR 0.26 -0.1057 AstraZeneca PLC ADR outperforms market despite losses on the day - MarketWatch 11/29/2022, 16:40:00
AZN Astrazeneca plc - ADR 0.26 -0.1057 Moderna Inc. stock falls Wednesday, underperforms market - MarketWatch 11/23/2022, 16:31:00
AZN Astrazeneca plc - ADR 0.26 -0.1057 Pharma Co. Gains Approval for SARS-CoV-2 Drug Trending Company - Streetwise Reports 11/23/2022, 08:29:36
AZN Astrazeneca plc - ADR 0.26 -0.1057 Inovio Pharmaceuticals Inc. stock falls Tuesday, underperforms market - MarketWatch 11/22/2022, 17:01:00
AZN Astrazeneca plc - ADR 0.26 -0.1057 AbbVie Inc. stock rises Tuesday, outperforms market - MarketWatch 11/22/2022, 16:32:00
ZTS Zoetis Inc 0.26 -0.189 Equal Weight Maintains Significant Lead Over S&P 500 - ETF Trends 11/29/2022, 14:59:02
ZTS Zoetis Inc 0.26 -0.189 Hoof Protection and Health Care Seminar - Morning Ag Clips - 11/29/2022, 13:03:35
ZTS Zoetis Inc 0.26 -0.189 Top Stock Reports for Procter & Gamble, Coca-Cola & Progressive - Nasdaq 11/29/2022, 10:42:00
ZTS Zoetis Inc 0.26 -0.189 2022-11-29 NYSE:ZTS Press Release Zoetis Inc. Class A - Stockhouse 11/29/2022, 09:18:44
ZTS Zoetis Inc 0.26 -0.189 Poultry Disinfectant Global Market Report 2022: Ukraine-Russia War Impact - Yahoo Finance 11/29/2022, 08:48:00
ACRS Aclaris Therapeutics Inc 0.26 0 Astrazeneca paying up to $320M to acquire individualized TCR T-cell therapy developer Neogene - BioWorld Online 11/29/2022, 12:00:00
ACRS Aclaris Therapeutics Inc 0.26 0 Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China - GlobeNewswire 11/29/2022, 07:00:00
ACRS Aclaris Therapeutics Inc 0.26 0 Androgenetic Alopecia Treatment Market Value Projected to Expand by 2030 Histogen Inc, Cipla Limited, Aclaris Therapeutics - Digital Journal 11/28/2022, 09:56:20
ACRS Aclaris Therapeutics Inc 0.26 0 Alopecia Treatment Market Research Report 2022 – Size, Share, Emerging Trends, Historic Analysis, Industry Growth Factors, Forecast to 2028 Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla - Digital Journal 11/23/2022, 06:35:38
ACRS Aclaris Therapeutics Inc 0.26 0 Aclaris Therapeutics Announces Key Leadership Transitions - GlobeNewswire 11/22/2022, 16:01:00
VTRS Viatris Inc 0.25 1.085 Other news to note for Nov. 29, 2022 - BioWorld Online 11/29/2022, 17:41:50
VTRS Viatris Inc 0.25 1.085 Viscosupplementation Market Is Likely to Grasp the CAGR of 8.5 by 2029, Size, Share, Demand, Growth Drivers, Trends, Segmentation and Competitive Outlook - Yahoo Finance 11/29/2022, 16:30:00
VTRS Viatris Inc 0.25 1.085 Sector Update: Health Care Stocks Unable to Complete Tuesday Recovery MarketScreener - Marketscreener.com 11/29/2022, 16:02:04
VTRS Viatris Inc 0.25 1.085 The Global Peripheral Neuropathy Treatment Market is expected to grow by $372.56 mn from 2023-2027, accelerating at a CAGR of 3.81% during the forecast period - Yahoo Finance 11/29/2022, 13:28:00
VTRS Viatris Inc 0.25 1.085 US FDA Withdraws New Drug Application Approval for Viatris' Sulfamylon Cream - Marketscreener.com 11/29/2022, 13:24:03
NKTR Nektar Therapeutics 0.14 -6.129 Mirum blames enrollment woes for halting phase 2 trial for pregnancy liver disorder - FierceBiotech 11/29/2022, 09:56:03
NKTR Nektar Therapeutics 0.14 -6.129 Dual drug nanoparticle could curb chemo resistance - FierceBiotech 11/28/2022, 15:37:30
NKTR Nektar Therapeutics 0.14 -6.129 Sarepta-partnered Hansa touts new phase 2 data of one-trick pony immunological treatment - FierceBiotech 11/28/2022, 15:35:00
NKTR Nektar Therapeutics 0.14 -6.129 Master and PhD programs in pharmaceutical sciences underway Binghamton News - Binghamton 11/28/2022, 14:49:56
NKTR Nektar Therapeutics 0.14 -6.129 Gilead, Arcus hope to ease TIGIT anxieties with latest trial data tease - FierceBiotech 11/28/2022, 11:20:00
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 Noteworthy Tuesday Option Activity: AMGN, MDGL, NVCR - Nasdaq 11/29/2022, 16:51:00
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 The Liver Fibrosis Market Size in the 7MM was USD 2225 million in 2021 - Digital Journal 11/29/2022, 16:11:05
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 Akero Therapeutics: What Is Making The Stock Tick (NASDAQ:AKRO) - Seeking Alpha 11/23/2022, 11:01:00
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 Notable Friday Option Activity: MDGL, SAVA, MSTR - Nasdaq 11/18/2022, 03:00:00
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Short Interest Up 17.4% in October - MarketBeat 11/14/2022, 03:00:00
PRAX Praxis Precision Medicines Inc 0.14 9.1837 Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting - GlobeNewswire 11/28/2022, 16:05:00
PRAX Praxis Precision Medicines Inc 0.14 9.1837 Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal - FierceBiotech 11/28/2022, 10:53:00
PRAX Praxis Precision Medicines Inc 0.14 9.1837 Potential Modifier Gene Therapy for Degenerative Retinal Diseases - FierceBiotech 11/28/2022, 08:00:00
PRAX Praxis Precision Medicines Inc 0.14 9.1837 What is the Market's View on Praxis Precision Medicines Inc (PRAX) Stock's Price and Volume Trends Tuesday? - InvestorsObserver 11/22/2022, 12:48:45
PRAX Praxis Precision Medicines Inc 0.14 9.1837 Is Praxis Precision Medicines Inc (PRAX) a Stock to Watch After Gaining 22.50% This Week? - InvestorsObserver 11/09/2022, 11:52:14
GRAY Graybug Vision Inc 0.14 0.639 Glaucoma Pipeline Assessment 70+ Companies & 70+ Drugs DelveInsight - Digital Journal 11/29/2022, 16:16:47
GRAY Graybug Vision Inc 0.14 0.639 Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd - Yahoo Finance 11/28/2022, 12:08:00
GRAY Graybug Vision Inc 0.14 0.639 Ocular Drug Delivery Sales Market is expected to reach a value of USD 1721231.5 Million By 2027- OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside - Skegness Siren 11/26/2022, 07:15:49
GRAY Graybug Vision Inc 0.14 0.639 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BNFT, GRAY - Graybug Vision (NASDAQ:GRAY), Benef - Benzinga 11/24/2022, 07:30:51
GRAY Graybug Vision Inc 0.14 0.639 GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY - Business Wire 11/23/2022, 20:48:00
PRFX PainReform Ltd 0.14 -10.4167 Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday - Autodesk (NASDAQ - Benzinga 11/25/2022, 04:52:36
PRFX PainReform Ltd 0.14 -10.4167 Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday’s Mid-Day S - Benzinga 11/23/2022, 13:27:38
PRFX PainReform Ltd 0.14 -10.4167 PainReform Provides Business Update for the Third Quarter of 2022 - Yahoo Finance 11/15/2022, 03:00:00
PRFX PainReform Ltd 0.14 -10.4167 PainReform Provides Further Update on Manufacturing of PRF-110 - GlobeNewswire 11/08/2022, 08:30:00
PRFX PainReform Ltd 0.14 -10.4167 PainReform Provides PRF-110 Manufacturing Update - GlobeNewswire 10/04/2022, 03:00:00
SXTC China SXT Pharmaceuticals Inc 0.14 10.6593 Our Exclusive Articles - Benzinga 11/22/2022, 17:01:00
SXTC China SXT Pharmaceuticals Inc 0.14 10.6593 China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - GlobeNewswire 11/07/2022, 03:00:00
SXTC China SXT Pharmaceuticals Inc 0.14 10.6593 Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket - Black Diamond Ther - Benzinga 10/14/2022, 03:00:00
SXTC China SXT Pharmaceuticals Inc 0.14 10.6593 Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday - Agrif - Benzinga 10/13/2022, 03:00:00
SXTC China SXT Pharmaceuticals Inc 0.14 10.6593 Why T2 Biosystems Shares Are Trading Lower By Over 28%, Here Are 41 Stocks Moving In Wednesday’s Mid-Day - Benzinga 10/12/2022, 03:00:00
LCI Lannett Co., Inc. 0.13 -8.0496 Aclaris Therapeutics Announces Key Leadership Transitions - MyChesCo 11/28/2022, 02:00:24
LCI Lannett Co., Inc. 0.13 -8.0496 Obsessive-Compulsive Disorder Medicine Market by Product Type (NMDA Receptor Blockers, Antipsychotics, Antidepressants), Application (Hospitals, Homecare, Clinics, Others), and Geography – Global Trends & Forecasts to 2019-2029 – Skegness Si - Skegness Siren 11/26/2022, 03:28:57
LCI Lannett Co., Inc. 0.13 -8.0496 Alzheimer's Therapeutics Market Expected to Reach USD 14.20 Billion By 2030 With CAGR 16.2% - Digital Journal 11/22/2022, 06:59:17
LCI Lannett Co., Inc. 0.13 -8.0496 Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday - Arvinas (NASDAQ:ARVN) - Benzinga 11/22/2022, 03:49:19
LCI Lannett Co., Inc. 0.13 -8.0496 Gout Therapeutics Market to Expand at a CAGR of ~16% Assessment for the Driving Factors, Size, Revenue, Segments, Expansion, Demand, and Opportunities During 2022-2031 - Digital Journal 11/17/2022, 02:38:18
KDNY Chinook Therapeutics Inc 0.13 0.3467 Proteinuria Therapeutics Market Present Scenario and the Growth Prospects 2022 – 2028 GlaxoSmithKline plc - EIN News 11/29/2022, 07:09:00
KDNY Chinook Therapeutics Inc 0.13 0.3467 Primary Hyperoxaluria Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Primary Hyperoxaluria Pipeline Landscape - Digital Journal 11/25/2022, 12:02:57
KDNY Chinook Therapeutics Inc 0.13 0.3467 2022 Polycystic Kidney Disease Drugs in Development Report: Featuring Angion Biomedica, ATLAS Molecular Pharma, Bristol-Myers Squibb and Camurus Among Others - ResearchAndMarkets.com - WV News 11/25/2022, 06:48:39
KDNY Chinook Therapeutics Inc 0.13 0.3467 Chinook Therapeutics to Presen - GuruFocus.com 11/23/2022, 03:02:20
KDNY Chinook Therapeutics Inc 0.13 0.3467 Study estimates the lifetime benefit of combination therapy in patients with kidney disease without diabetes - EurekAlert 11/22/2022, 21:00:43
CRNX Crinetics Pharmaceuticals Inc 0.13 4.2278 Boston Scientific snatches up gastro-focused Apollo Endosurgery for $615M - FierceBiotech 11/29/2022, 12:54:14
CRNX Crinetics Pharmaceuticals Inc 0.13 4.2278 Almirall signs on for European clinical trial project to collect data for patients - FierceBiotech 11/29/2022, 10:36:01
CRNX Crinetics Pharmaceuticals Inc 0.13 4.2278 BigHat, cherry-picking opportunities amid stormy market, pens pact with Merck & Co. - FierceBiotech 11/29/2022, 08:05:06
CRNX Crinetics Pharmaceuticals Inc 0.13 4.2278 AstraZeneca inks $200M solid tumor TCR cell therapy buyout - FierceBiotech 11/29/2022, 07:01:16
CRNX Crinetics Pharmaceuticals Inc 0.13 4.2278 Spearing a sphere of MYC proteins could kill cancer cells - FierceBiotech 11/28/2022, 17:34:45
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Cannabis Cultivation Global Market Report 2022: Featuring Pacific Cannabis Growers, Atlas Growers, Canntrust Holdings, The Hydropothecary Corporation & Better Holdings - Yahoo Finance 11/29/2022, 05:38:00
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Magnetoencephalograph Market to Register Impressive Expansion of USD 393.91 Million with Excellent CAGR Of 4.90% by 2029 - Digital Journal 11/28/2022, 10:50:30
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Jazz Pharmaceuticals to Present Data Demonstrating Advancements in Epilepsy Outcomes at the 2022 American Epilepsy Society Annual Meeting Jazz Pharmaceuticals plc - JAZZ's Investor Relations 11/28/2022, 08:18:23
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Goldman Sachs, Walmart And These 2 Stocks Insiders Are Selling - Jazz Pharmaceuticals (NASDAQ:JAZZ), Gold - Benzinga 11/28/2022, 07:40:07
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Jet Lag Therapy Treatment Market Size – In-depth Analysis Report, Overview, Demand, Top Players, and Current Trends with Forecast to 2028 - Digital Journal 11/28/2022, 05:40:34
SAGE Sage Therapeutics Inc 0.13 1.4768 IntegriChain Distribution Experts to Speak at Informa Trade & Channel Strategies - El Paso Inc. 11/29/2022, 08:28:21
SAGE Sage Therapeutics Inc 0.13 1.4768 Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat 11/29/2022, 01:46:05
SAGE Sage Therapeutics Inc 0.13 1.4768 Postpartum Depression Drug Market to Reflect Steady Growth Rate by 2028 Sage Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited. - Digital Journal 11/24/2022, 02:39:21
SAGE Sage Therapeutics Inc 0.13 1.4768 Gene therapy Hemgenix gains FDA clearance for hemophilia B - BioWorld Online 11/23/2022, 13:16:02
SAGE Sage Therapeutics Inc 0.13 1.4768 Alzheimer's Disease Pharmaceutical and Healthcare Latest Pipeline Guide - openPR 11/23/2022, 10:56:00
NRIX Nurix Therapeutics Inc 0.13 3.348 Til Therapy Market May Set New Growth Story Nurix Therapeutics, Achilles Therapeutics, Intima Bioscience - Digital Journal 11/28/2022, 07:32:06
NRIX Nurix Therapeutics Inc 0.13 3.348 We're Keeping An Eye On Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn Rate - Simply Wall St 11/28/2022, 05:20:48
NRIX Nurix Therapeutics Inc 0.13 3.348 Nurix Announces DeTIL-0255 Scientific Presentations at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) and Successful Completion of DeTIL-0255 Phase 1 Safety Run-in - GlobeNewswire 11/10/2022, 03:00:00
NRIX Nurix Therapeutics Inc 0.13 3.348 Cathie Wood's ARKK ETF Heads for Best Day Ever as Risk Assets Surge - Bloomberg 11/10/2022, 03:00:00
NRIX Nurix Therapeutics Inc 0.13 3.348 Nurix Therapeutics Announces Presentations at the 64th American Society of Hematology (ASH) Annual Meeting - GlobeNewswire 11/03/2022, 03:00:00
AXSM Axsome Therapeutics Inc 0.13 -5.2047 Company Innovation Scorecard - Ranking 3500 Innovative Companies on Activity, Impact and Disruptive Potential of their Intellectual Property (IP) Portfolio - ResearchAndMarkets.com - Business Wire 11/29/2022, 11:27:00
AXSM Axsome Therapeutics Inc 0.13 -5.2047 Second Recipient Of Eisai/Biogen Alzheimer's Trial Treatment Dies - Kaiser Health News 11/29/2022, 08:54:06
AXSM Axsome Therapeutics Inc 0.13 -5.2047 FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday - CinCor Pharma (NASDAQ:CINC) - Benzinga 11/29/2022, 07:24:15
AXSM Axsome Therapeutics Inc 0.13 -5.2047 Five things for pharma marketers to know: Tuesday, November 29, 2022 - MM+M Online 11/29/2022, 05:01:27
AXSM Axsome Therapeutics Inc 0.13 -5.2047 Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today - Appl - Benzinga 11/28/2022, 20:02:36
MBRX Moleculin Biotech Inc 0.13 7.5758 Our Exclusive Articles - Benzinga 11/29/2022, 12:59:54
MBRX Moleculin Biotech Inc 0.13 7.5758 Celularity, Moleculin Biotech And 2 Other Penny Stocks Insiders Are Aggressively Buying - Celularity (NAS - Benzinga 11/29/2022, 06:11:46
MBRX Moleculin Biotech Inc 0.13 7.5758 Walter V. Klemp Buys 45000 Shares of Moleculin Biotech, Inc. (NASDAQ:MBRX) Stock - ETF Daily News 11/29/2022, 04:58:22
MBRX Moleculin Biotech Inc 0.13 7.5758 Healthcare Stocks Making Moves Tuesday: PALI, BCLI, ACHV, MBRX, QTNT, CFMS, CDIO, ATNM - InvestorsObserver 11/22/2022, 15:02:45
MBRX Moleculin Biotech Inc 0.13 7.5758 Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday - Arvinas (NASDAQ:ARVN) - Benzinga 11/22/2022, 03:49:19
BPTS Biophytis - ADR 0.13 -10 BPTS Stock Forecast, Price & News (Biophytis) - MarketBeat 02/10/2021, 21:19:51
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 DDoS as threat to e-commerce. Meta's GDPR fine. TikTok challenge spreads malware. US CYBERCOM's support for Ukraine. - The CyberWire 11/29/2022, 14:14:19
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 Lice Treatment Market Study Providing Information on Top Key Players Bayer, Alliance Pharmaceuticals Ltd, Omega Pharma, Azurity Pharmaceuticals And More - Digital Journal 11/29/2022, 07:36:17
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 Haleon Voted Company Of The Year At The OTC Marketing Awards 2022 - HBW Insight 11/29/2022, 04:54:21
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 10 things to know about global access to healthcare - Philips 11/29/2022, 02:00:00
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 Apple To Buy Manchester United? A Futuristic Buy (NASDAQ:AAPL) - Seeking Alpha 11/28/2022, 09:13:00
CALT Calliditas Therapeutics AB - ADR 0.13 -2.8011 Aurinia (AUPH) Moves 13.1% Higher: Will This Strength Last? - Zacks Investment Research 10/21/2022, 03:00:00
CALT Calliditas Therapeutics AB - ADR 0.13 -2.8011 CALT Stock Forecast, Price & News (Calliditas Therapeutics AB (publ)) - MarketBeat 06/30/2020, 11:53:07
CALT Calliditas Therapeutics AB - ADR 0.13 -2.8011 CALT News Today Why did Calliditas Therapeutics AB (publ) stock go down today? - MarketBeat 06/30/2020, 08:07:35
ANNX Annexon Inc 0.13 -3.3854 Amyotrophic Lateral Sclerosis Clinical Trials, Pipeline Assessment Insights into the Current Therapies, Emer - openPR 11/29/2022, 06:15:00
ANNX Annexon Inc 0.13 -3.3854 New affordable housing groundbreaking at Gladstone School building in Hazelwood - CBS Pittsburgh 11/21/2022, 15:57:00
ANNX Annexon Inc 0.13 -3.3854 We're Keeping An Eye On Annexon's (NASDAQ:ANNX) Cash Burn Rate - Yahoo Finance 11/21/2022, 06:13:02
ANNX Annexon Inc 0.13 -3.3854 Iveric Bio Inc: ISEE Stock's Eye Watering Rise - Value the Markets 11/18/2022, 03:00:00
ANNX Annexon Inc 0.13 -3.3854 Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - Marketscreener.com 11/17/2022, 16:02:02
AMRN Amarin Corp - ADR 0.07 0 Hopes for Black Friday Boost to Economy Nudge European Equities Higher - InvestorsObserver 11/25/2022, 12:56:43
AMRN Amarin Corp - ADR 0.07 0 Eurozone PMI Data Supports European Equities - InvestorsObserver 11/23/2022, 11:21:52
AMRN Amarin Corp - ADR 0.07 0 European ADRs Continue to Trend Higher in Monday Trading - InvestorsObserver 11/14/2022, 11:08:41
AMRN Amarin Corp - ADR 0.07 0 Premarket Mover: Amarin Corporation plc (AMRN) Down 3.73% - InvestorsObserver 11/14/2022, 07:24:47
AMRN Amarin Corp - ADR 0.07 0 European ADRs Move Lower in Monday Trading - InvestorsObserver 10/31/2022, 12:14:37
ARDS Aridis Pharmaceuticals Inc 0.02 -8.5377 Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases - GlobeNewswire 11/22/2022, 09:10:00
ARDS Aridis Pharmaceuticals Inc 0.02 -8.5377 Aridis Pharmaceuticals (ARDS) Reports Q3 Loss, Misses Revenue Estimates - Nasdaq 11/21/2022, 19:55:00
ARDS Aridis Pharmaceuticals Inc 0.02 -8.5377 Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update - Yahoo Finance 11/21/2022, 18:30:00
ARDS Aridis Pharmaceuticals Inc 0.02 -8.5377 Will Aridis Pharmaceuticals Inc (ARDS) Outperform the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver 11/17/2022, 11:22:39
ARDS Aridis Pharmaceuticals Inc 0.02 -8.5377 Form NT 10-Q Aridis Pharmaceuticals, For: Sep 30 - StreetInsider.com 11/15/2022, 06:45:44
JUPW Jupiter Wellness Inc 0.02 -7.6923 Interior Design Services Market 2023-2027: A Descriptive Analysis of Parent Market, Five Forces Model, Market Dynamics, & Segmentation - Technavio - Yahoo Finance 11/28/2022, 11:00:00
JUPW Jupiter Wellness Inc 0.02 -7.6923 Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday By Benzinga - Investing.com UK 11/25/2022, 09:13:00
JUPW Jupiter Wellness Inc 0.02 -7.6923 Healthcare Stocks Making Moves Wednesday: NRBO, NMTC, XGN, GLSI, BIOL, PRE, JUPW, CCCC - InvestorsObserver 11/23/2022, 14:27:27
JUPW Jupiter Wellness Inc 0.02 -7.6923 Regaining NASDAQ Compliance; Jupiter Wellness, Inc. (NASDAQ: JUPW) Bio-Pharma- Wellness Developer with Di - Benzinga 11/22/2022, 10:56:02
JUPW Jupiter Wellness Inc 0.02 -7.6923 JUPITER WELLNESS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/18/2022, 14:10:05
ISR Isoray, Inc. 0.02 -0.1556 ISORAY, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/29/2022, 16:29:03
ISR Isoray, Inc. 0.02 -0.1556 Radiotherapy Market 2022 Future Business Opportunities for Business Development Forecasts Up to 2030: Accuray Incorporated, Elekta, Isoray, CIVCO, Hitachi, Ltd., Mevion Medical Systems - Digital Journal 11/29/2022, 05:54:48
ISR Isoray, Inc. 0.02 -0.1556 Radiotherapy Market: Size, Share, Growth, Trends Current Analysis and Forecast (2022-2028) - EIN News 11/28/2022, 12:53:00
ISR Isoray, Inc. 0.02 -0.1556 Veterinary Stereotactic Radiosurgery System Market Report 2022 With Up To 70% Discount On Purchase Includes Demographic Trends, New Developments, Company Performance and Forecast 2029: PetCure Oncology (U.S.), Varian Medical Systems Inc. ( - Digital Journal 11/25/2022, 03:49:04
ISR Isoray, Inc. 0.02 -0.1556 The Global Radiation Oncology Devices Market to Climb Swiftly at a CAGR of 7.78% by 2027 DelveInsight - Medgadget 11/24/2022, 06:43:33
AKTX Akari Therapeutics Plc - ADR 0.02 -6.8621 AKTX Stock Forecast, Price & News (Akari Therapeutics) - MarketBeat 08/11/2016, 19:18:55
TXMD TherapeuticsMD Inc 0.02 7.565 TherapeuticsMD Inc. stock outperforms market on strong trading day - MarketWatch 11/29/2022, 17:41:00
TXMD TherapeuticsMD Inc 0.02 7.565 Bio-identical Hormones Market – Porter's Five Forces Strategy Analysis and Forecast 2028 TherapeuticsMD, Inc., BioTE Medical, Defy Medical and SottoPelle. - Digital Journal 11/28/2022, 07:47:46
TXMD TherapeuticsMD Inc 0.02 7.565 Should You Accumulate TherapeuticsMD Inc (TXMD) Stock Friday? - InvestorsObserver 11/25/2022, 13:36:56
TXMD TherapeuticsMD Inc 0.02 7.565 TherapeuticsMD Inc. stock falls Friday, underperforms market - MarketWatch 11/18/2022, 03:00:00
TXMD TherapeuticsMD Inc 0.02 7.565 Bioidentical Hormones Market is Projected to Showcase Significant Growth up to 2029 Noven Pharmaceuticals, Novartis AG, Sottepolle, BioTE Medical, Pfizer Inc., TherapeuticsMD Inc, Bayer AG, Novo Nordisk A/S – The C-Drone Review - The C-Drone Review 11/18/2022, 01:43:53
MEIP MEI Pharma Inc 0.02 -4.1621 ASH: BeiGene deals all-around blow to Imbruvica in CLL - FiercePharma 11/22/2022, 09:00:00
MEIP MEI Pharma Inc 0.02 -4.1621 Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma in Japan - Marketscreener.com 11/21/2022, 08:11:08
MEIP MEI Pharma Inc 0.02 -4.1621 Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP) - Simply Wall St 11/19/2022, 03:00:00
MEIP MEI Pharma Inc 0.02 -4.1621 The Top 25 Healthcare Technology Leaders of San Diego for 2022 - The Healthcare Technology Report. 11/15/2022, 12:00:00
MEIP MEI Pharma Inc 0.02 -4.1621 QPS OPENS ADDITIONAL PRECLINICAL RESEARCH FACILITY IN TAIPEI, TAIWAN - PR Newswire 11/15/2022, 07:52:00
OCUP Ocuphire Pharma Inc 0.02 5.3872 Glaucoma Pipeline Assessment 70+ Companies & 70+ Drugs DelveInsight - Digital Journal 11/29/2022, 16:16:47
OCUP Ocuphire Pharma Inc 0.02 5.3872 Ocular Hypertension Therapeutic Pipeline Analysis, 2022 In-depth Insights into the Latest FDA, EMA, and PMDA - openPR 11/28/2022, 04:31:00
OCUP Ocuphire Pharma Inc 0.02 5.3872 2022-11-21 NDAQ:OCUP Press Release Ocuphire Pharma Inc. - Stockhouse 11/21/2022, 08:06:39
OCUP Ocuphire Pharma Inc 0.02 5.3872 Ocuphire to Present at Five Up - GuruFocus.com 11/21/2022, 08:02:08
OCUP Ocuphire Pharma Inc 0.02 5.3872 Other news to note for Nov. 15, 2022 - BioWorld Online 11/15/2022, 03:00:00
SEEL Seelos Therapeutics Inc 0.02 -4.1611 COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference - Investing News Network 11/28/2022, 16:28:22
SEEL Seelos Therapeutics Inc 0.02 -4.1611 Albert Labs Announces Private Placement - Investing News Network 11/25/2022, 09:37:23
SEEL Seelos Therapeutics Inc 0.02 -4.1611 SEELOS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com 11/23/2022, 16:06:08
SEEL Seelos Therapeutics Inc 0.02 -4.1611 Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 - PR Newswire 11/23/2022, 08:00:00
SEEL Seelos Therapeutics Inc 0.02 -4.1611 Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction - Investing News Network 11/21/2022, 09:35:32
RVMD Revolution Medicines Inc 0.02 5.2045 Lebanese troops called in to halt drug turf war - Arab News 11/29/2022, 12:31:13
RVMD Revolution Medicines Inc 0.02 5.2045 Brothers among 5 Palestinians killed in West Bank - Arab News 11/29/2022, 11:38:49
RVMD Revolution Medicines Inc 0.02 5.2045 Investors are poised to add Revolution Medicines Inc. (RVMD) Stock to their long term portfolios - MZP News 11/29/2022, 11:24:00
RVMD Revolution Medicines Inc 0.02 5.2045 IRGC threatens Iranian footballers' families ahead of US match - Arab News 11/29/2022, 07:23:50
RVMD Revolution Medicines Inc 0.02 5.2045 Form 6-K ASTRAZENECA PLC For: Nov 29 - StreetInsider.com 11/29/2022, 06:52:07
PFE Pfizer Inc. 0.01 -0.1614 13 Best Biotech Penny Stocks To Buy Now - Yahoo Finance 11/29/2022, 17:43:35
PFE Pfizer Inc. 0.01 -0.1614 TherapeuticsMD Inc. stock outperforms market on strong trading day - MarketWatch 11/29/2022, 17:41:00
PFE Pfizer Inc. 0.01 -0.1614 Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch 11/29/2022, 17:27:00
PFE Pfizer Inc. 0.01 -0.1614 Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch 11/29/2022, 17:24:00
PFE Pfizer Inc. 0.01 -0.1614 Merck & Co. Inc. stock rises Tuesday, outperforms market - MarketWatch 11/29/2022, 17:20:00